Open access
Aug 2026
Exploring the anti-Helicobacter pylori activity of Guluchyadi Kashayam through in-vitro and in-silico analysis
The β-clamp protein is identified as a therapeutic target and CID 546,407 as a promising lead for drug development, driven by robust Van der Waals forces, which avoids the massive entropic penalties hindering other compounds.
Priya Venugopal, Abel Koshy, Anuroopa G. Nadh et al.
· In Silico Pharmacology · 0 citations